The spike protein of SARS-CoV — a target for vaccine and therapeutic development
The spike protein of SARS-CoV — a target for vaccine and therapeutic development
About this item
Full title
Author / Creator
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Key Points
This Review provides an overview on the spike (S) protein of severe acute respiratory syndrome-coronavirus (SARS-CoV) as a target for the development of vaccines and therapeutics for the prevention and treatment of SARS.
SARS is a newly emerging infectious disease, caused by SARS-CoV, a novel coronavirus that caused a global outbre...
Alternative Titles
Full title
The spike protein of SARS-CoV — a target for vaccine and therapeutic development
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2750777
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2750777
Other Identifiers
ISSN
1740-1526
E-ISSN
1740-1534
DOI
10.1038/nrmicro2090
